Financial statements Tactica Pharmaceuticals
Balance sheet data of TACTICA PHARMACEUTICALS
|
Year
|
2018
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 42 006 332,30 | 51 792 645,76 | 64 161 842,11 | 81 837 181,72 |
| A. Fixed assets | 5 530 971,98 | 10 979 353,48 | 13 892 818,95 | 24 080 485,26 |
| B. Current assets | 36 475 360,32 | 40 813 292,28 | 50 269 023,16 | 57 756 696,46 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 42 006 332,30 | 51 792 645,76 | 64 161 842,11 | 81 837 181,72 |
| A. Equity | 26 217 010,94 | 36 563 771,62 | 37 629 897,03 | 48 416 823,00 |
| B. Liabilities and provisions for liabilities | 15 789 321,36 | 15 228 874,14 | 26 531 945,08 | 33 420 358,72 |
| I. Long-term liabilities | 2 272 977,31 | 1 989 337,18 | 4 342 638,07 | 8 886 060,55 |
| II. Short-term liabilities | 13 477 278,14 | 13 239 536,96 | 22 072 045,68 | 23 986 970,84 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.